Cameron John Turtle MD
Instructor, Medicine, University of Washington School of Medicine
Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-228-1025
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 12 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cameron Turtle, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with UW Medicine/University of Washington Medical Center and is an Instructor at University of Washington School of Medicine.
Education & Training
University of Sydney Faculty of MedicineClass of 1993
Certifications & Licensure
WA State Medical License 2007 - 2022
Clinical Trials
- JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Start of enrollment: 2016 Nov 15
- huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia Start of enrollment: 2017 Nov 03
Publications & Presentations
PubMed
- CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis.Swetha Kambhampati Thiruvengadam, Kwang Woo Ahn, Jinalben Patel, Qinghua Lian, Mark Hertzberg
American Journal of Hematology. 2025-08-05 - Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis.Kalyan V Nadiminti, Kwang W Ahn, Jinalben Patel, Qinghua Lian, Evandro Bezerra
Transplantation and Cellular Therapy. 2025-08-01 - A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up.Sherilyn A Tuazon, Andrew J Portuguese, Margot J Pont, Andrew J Cowan, Gabriel O Cole
Blood. 2025-07-31
Press Mentions
Patient and Family Experience with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) and Polyneuropathy (ATTR-PN) Amyloidosis: Results of Two Focus GroupsFebruary 8th, 2021- Eureka Therapeutics Appoints Nobel Laureate Randy Schekman, Ph.D. To Its Scientific Advisory BoardNovember 9th, 2020
Fred Hutch at ASH: Latest CAR T Data – BCMA, CD19, CD20 – plus New Insights on Transplantation, Gene Therapy – and MoreNovember 21st, 2019- Join now to see all
